Shainaba A Saadhali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shainaba A Saadhali has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sameer Hassan
Department of Biological and Environmental Sciences, University of Gothenburg, Box 461, 405 30 Gothenburg, Sweden
2 shared publications - Vanaja Kumar
NIRTH: ICMR-National Institute of Research in Tribal Health
2 shared publications Amudha Prabu
Department of Bacteriology, National Institute for Research in Tuberculosis, Chetpet, Chennai 600031, India
1 shared publication- Benjamin Isaac Thomson
Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India
1 shared publication Luke Elizabeth Hanna
Department of Clinical Research, National Institute for Research in Tuberculosis, Chennai, 600031, India
1 shared publication- Luke Elizabeth Hanna
Department of Virology and Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chetpet, Chennai, 600031, India
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 22 (3) , 914-922
Efflux Pump Inhibitors and their Role in Combating Bacterial Drug Resistance
The use of efflux pump inhibitors (EPIs) as adjuvant therapy to combat bacterial resistance to several antibiotics has been a proven method to fight antimicrobial resistance. Antibiotic- expelling efflux pumps, which are found in bacterial cell membranes, play a major role in the development of multidrug resistance. Therefore, EPIs, which are meant to inhibit these pumps, have the potential to make the current antibiotic arsenal more effective. Here we classify efflux pumps, analyse the many complexities of EPI processes, and emphasize the range of sources and applications. This academic review thus highlights the functioning of efflux pumps, the critical role that efflux pump inhibitors play and advocates for more research into efflux pump inhibitors.
- 30 September 2025
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 22 (3) , 914-922
Open AccessEfflux Pump Inhibitors and their Role in Combating Bacterial Drug Resistance
The use of efflux pump inhibitors (EPIs) as adjuvant therapy to combat bacterial resistance to several antibiotics has been a proven method to fight antimicrobial resistance. Antibiotic- expelling efflux pumps, which are found in bacterial cell membranes, play a major role in the development of multidrug resistance. Therefore, EPIs, which are meant to inhibit these pumps, have the potential to make the current antibiotic arsenal more effective. Here we classify efflux pumps, analyse the many complexities of EPI processes, and emphasize the range of sources and applications. This academic review thus highlights the functioning of efflux pumps, the critical role that efflux pump inhibitors play and advocates for more research into efflux pump inhibitors.
- 13 July 2016
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 22 (8) , 1-12
Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A
Mycobacteriophages produce lysins that break down the host cell wall at the end of lytic cycle to release their progenies. The ability to lyse mycobacterial cells makes the lysins significant. Mycobacteriophage Che12 is the first reported temperate phage capable of infecting and lysogenising Mycobacterium tuberculosis. Gp11 of Che12 was found to have Chitinase domain that serves as endolysin (lysin A) for Che12. Structure of gp11 was modeled and evaluated using Ramachandran plot in which 98 % of the residues are in the favored and allowed regions. Che12 lysin A was predicted to act on NAG-NAM-NAG molecules in the peptidoglycan of cell wall. The tautomers of NAG-NAM-NAG molecule were generated and docked with lysin A. The stability and binding affinity of lysin A – NAG-NAM-NAG tautomers were studied using molecular dynamics simulations.
- 13 July 2016
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 22 (8) , 1-12
Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A
Mycobacteriophages produce lysins that break down the host cell wall at the end of lytic cycle to release their progenies. The ability to lyse mycobacterial cells makes the lysins significant. Mycobacteriophage Che12 is the first reported temperate phage capable of infecting and lysogenising Mycobacterium tuberculosis. Gp11 of Che12 was found to have Chitinase domain that serves as endolysin (lysin A) for Che12. Structure of gp11 was modeled and evaluated using Ramachandran plot in which 98 % of the residues are in the favored and allowed regions. Che12 lysin A was predicted to act on NAG-NAM-NAG molecules in the peptidoglycan of cell wall. The tautomers of NAG-NAM-NAG molecule were generated and docked with lysin A. The stability and binding affinity of lysin A – NAG-NAM-NAG tautomers were studied using molecular dynamics simulations.
- 1 September 2015
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 61, 133-140
Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2′-N-acetyltransferase in Mycobacterium tuberculosis
- 1 September 2015
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 61, 133-140
Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2′-N-acetyltransferase in Mycobacterium tuberculosis